ArticleJournal of the American Society of Nephrology : JASN2022

Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study.

Eugene Yu-Hin Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.